甲状腺乳頭癌治療の世界市場成長率 2023-2029Global Papillary Thyroid Cancer Treatment Market Growth 2023-2029 世界の乳頭状甲状腺癌治療の市場規模は、2022年の2690.2百万米ドルから2029年には3780.2百万米ドルに成長すると予測され、2023年から2029年までのCAGRは5.0%と予測されています。 乳頭状甲状腺癌治療薬の米国市... もっと見る
サマリー世界の乳頭状甲状腺癌治療の市場規模は、2022年の2690.2百万米ドルから2029年には3780.2百万米ドルに成長すると予測され、2023年から2029年までのCAGRは5.0%と予測されています。乳頭状甲状腺癌治療薬の米国市場は、2023年から2029年までのCAGRで、2022年の100万米ドルから2029年には100万米ドルに増加すると予測されています。 乳頭状甲状腺癌治療の中国市場は、2023年から2029年までのCAGR %で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されます。 乳頭状甲状腺癌治療のヨーロッパ市場は、2023年から2029年までのCAGR %で、2022年の百万米ドルから2029年までに百万米ドルに増加すると推定されます。 世界の主要な乳頭状甲状腺癌治療のプレーヤーは、Mylan pharmaceuticals Inc.、Baxter International Inc.、Alara Pharmaceutical Corporation、Abbott laboratories、Bristol Myers co.、Teva parenteral medicines Inc.、Jerome Stevens Pharmaceuticals Inc.、メルクおよびノバルティスなどをカバーしています。収益面では、世界の2大企業が2022年にほぼ%のシェアを占めています。 甲状腺乳頭がんは、甲状腺がんの中で最も一般的なタイプであり、甲状腺がん全体の75%から85%を占めています。女性に多く発症し、20〜55歳の年齢層に発症します。また、小児甲状腺がんや、頭頸部に放射線照射を受けたことのある甲状腺がん患者さんでは、このタイプのがんが多くみられます。転移することもありますが、高分化型、低成長、限局型であることが多いです。 LPI(エルピーアイ)の最新リサーチレポート「甲状腺乳頭癌治療産業の予測」は、過去の売上高を調べ、2022年の世界の甲状腺乳頭癌治療の総売上高を検討し、2023年から2029年の甲状腺乳頭癌治療の予測売上を地域と市場分野ごとに包括的に分析しています。本レポートでは、乳頭状甲状腺癌治療の売上を地域別、市場分野別、サブセクター別に分類し、世界の乳頭状甲状腺癌治療産業の詳細な分析(百万米ドル単位)を提供します。 本インサイトレポートでは、世界の乳頭状甲状腺癌治療の状況を包括的に分析し、製品区分、会社設立、収益、市場シェア、最新開発、M&A活動に関する主要動向を明らかにします。また、本レポートでは、加速する世界のパピラリ甲状腺がん治療市場におけるこれらの企業の独自のポジションをより良く理解するために、パピラリ甲状腺がん治療のポートフォリオと能力、市場参入戦略、市場ポジション、地理的フットプリントに焦点を当てて、主要グローバル企業の戦略を分析しています。 本インサイトレポートでは、乳頭状甲状腺がん治療の世界的な見通しを形成する主要な市場動向、推進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を行い、新たな機会のポケットを明らかにします。何百ものボトムアップの定性的・定量的な市場インプットに基づく透明性の高い手法により、この調査予測は、世界の乳頭状甲状腺癌治療の現状と将来の軌道について非常にニュアンスのある見方を提供します。 本レポートでは、製品タイプ、用途、主要メーカー、主要地域・国別に、甲状腺乳頭癌治療市場の包括的な概要、市場シェア、成長機会について紹介します。 市場のセグメンテーション タイプ別セグメンテーション 手術療法 ヨード治療 サイロキシン治療 化学療法 その他 用途別セグメント 病院薬局 小売薬局 オンライン薬局 また、本レポートでは、地域別に市場を分割しています: 米州 アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア 欧州 ドイツ フランス イギリス イタリア ロシア 中近東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、主要な専門家から収集した情報、企業のカバレッジ、製品ポートフォリオ、市場浸透度を分析した上で選定されています。 マイラン・ファーマシューティカルズInc. バクスター・インターナショナル・インク アララ・ファーマシューティカル・コーポレーション アボット ラボラトリーズ ブリストル・マイヤーズ株式会社 テバ・ペレンタラル・メディシンズInc. ジェローム・スティーブンス・ファーマシューティカルズInc. メルク ノバルティス ファイザー サノフィ ギャラクソ・スミスクライン バイオジェン・アイデック バイエル ヘルスケア ファーマシューティカルズ ジョンソン・エンド・ジョンソン トレロ・ファーマシューティカル 本レポートで扱う主な質問 世界の甲状腺乳頭癌治療薬市場の10年後の展望は? 世界および地域別に、乳頭状甲状腺がん治療薬市場の成長を促進する要因は何か? 市場別、地域別に最も速い成長を遂げる技術は何か? 乳頭状甲状腺がん治療の市場機会は、エンドマーケットの規模によってどのように変化するのか? 乳頭状甲状腺がん治療薬のタイプ別、用途別内訳は? COVID-19とロシア・ウクライナ戦争の影響とは? 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Papillary Thyroid Cancer Treatment Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Papillary Thyroid Cancer Treatment by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Papillary Thyroid Cancer Treatment by Country/Region, 2018, 2022 & 2029 2.2 Papillary Thyroid Cancer Treatment Segment by Type 2.2.1 Surgery 2.2.2 Iodine Therapy 2.2.3 Thyroxin Treatment 2.2.4 Chemotherapy 2.2.5 Others 2.3 Papillary Thyroid Cancer Treatment Sales by Type 2.3.1 Global Papillary Thyroid Cancer Treatment Sales Market Share by Type (2018-2023) 2.3.2 Global Papillary Thyroid Cancer Treatment Revenue and Market Share by Type (2018-2023) 2.3.3 Global Papillary Thyroid Cancer Treatment Sale Price by Type (2018-2023) 2.4 Papillary Thyroid Cancer Treatment Segment by Application 2.4.1 Hospital Pharmacies 2.4.2 Retail Pharmacies 2.4.3 Online Pharmacies 2.5 Papillary Thyroid Cancer Treatment Sales by Application 2.5.1 Global Papillary Thyroid Cancer Treatment Sale Market Share by Application (2018-2023) 2.5.2 Global Papillary Thyroid Cancer Treatment Revenue and Market Share by Application (2018-2023) 2.5.3 Global Papillary Thyroid Cancer Treatment Sale Price by Application (2018-2023) 3 Global Papillary Thyroid Cancer Treatment by Company 3.1 Global Papillary Thyroid Cancer Treatment Breakdown Data by Company 3.1.1 Global Papillary Thyroid Cancer Treatment Annual Sales by Company (2018-2023) 3.1.2 Global Papillary Thyroid Cancer Treatment Sales Market Share by Company (2018-2023) 3.2 Global Papillary Thyroid Cancer Treatment Annual Revenue by Company (2018-2023) 3.2.1 Global Papillary Thyroid Cancer Treatment Revenue by Company (2018-2023) 3.2.2 Global Papillary Thyroid Cancer Treatment Revenue Market Share by Company (2018-2023) 3.3 Global Papillary Thyroid Cancer Treatment Sale Price by Company 3.4 Key Manufacturers Papillary Thyroid Cancer Treatment Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Papillary Thyroid Cancer Treatment Product Location Distribution 3.4.2 Players Papillary Thyroid Cancer Treatment Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Papillary Thyroid Cancer Treatment by Geographic Region 4.1 World Historic Papillary Thyroid Cancer Treatment Market Size by Geographic Region (2018-2023) 4.1.1 Global Papillary Thyroid Cancer Treatment Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Papillary Thyroid Cancer Treatment Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Papillary Thyroid Cancer Treatment Market Size by Country/Region (2018-2023) 4.2.1 Global Papillary Thyroid Cancer Treatment Annual Sales by Country/Region (2018-2023) 4.2.2 Global Papillary Thyroid Cancer Treatment Annual Revenue by Country/Region (2018-2023) 4.3 Americas Papillary Thyroid Cancer Treatment Sales Growth 4.4 APAC Papillary Thyroid Cancer Treatment Sales Growth 4.5 Europe Papillary Thyroid Cancer Treatment Sales Growth 4.6 Middle East & Africa Papillary Thyroid Cancer Treatment Sales Growth 5 Americas 5.1 Americas Papillary Thyroid Cancer Treatment Sales by Country 5.1.1 Americas Papillary Thyroid Cancer Treatment Sales by Country (2018-2023) 5.1.2 Americas Papillary Thyroid Cancer Treatment Revenue by Country (2018-2023) 5.2 Americas Papillary Thyroid Cancer Treatment Sales by Type 5.3 Americas Papillary Thyroid Cancer Treatment Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Papillary Thyroid Cancer Treatment Sales by Region 6.1.1 APAC Papillary Thyroid Cancer Treatment Sales by Region (2018-2023) 6.1.2 APAC Papillary Thyroid Cancer Treatment Revenue by Region (2018-2023) 6.2 APAC Papillary Thyroid Cancer Treatment Sales by Type 6.3 APAC Papillary Thyroid Cancer Treatment Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Papillary Thyroid Cancer Treatment by Country 7.1.1 Europe Papillary Thyroid Cancer Treatment Sales by Country (2018-2023) 7.1.2 Europe Papillary Thyroid Cancer Treatment Revenue by Country (2018-2023) 7.2 Europe Papillary Thyroid Cancer Treatment Sales by Type 7.3 Europe Papillary Thyroid Cancer Treatment Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Papillary Thyroid Cancer Treatment by Country 8.1.1 Middle East & Africa Papillary Thyroid Cancer Treatment Sales by Country (2018-2023) 8.1.2 Middle East & Africa Papillary Thyroid Cancer Treatment Revenue by Country (2018-2023) 8.2 Middle East & Africa Papillary Thyroid Cancer Treatment Sales by Type 8.3 Middle East & Africa Papillary Thyroid Cancer Treatment Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Papillary Thyroid Cancer Treatment 10.3 Manufacturing Process Analysis of Papillary Thyroid Cancer Treatment 10.4 Industry Chain Structure of Papillary Thyroid Cancer Treatment 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Papillary Thyroid Cancer Treatment Distributors 11.3 Papillary Thyroid Cancer Treatment Customer 12 World Forecast Review for Papillary Thyroid Cancer Treatment by Geographic Region 12.1 Global Papillary Thyroid Cancer Treatment Market Size Forecast by Region 12.1.1 Global Papillary Thyroid Cancer Treatment Forecast by Region (2024-2029) 12.1.2 Global Papillary Thyroid Cancer Treatment Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Papillary Thyroid Cancer Treatment Forecast by Type 12.7 Global Papillary Thyroid Cancer Treatment Forecast by Application 13 Key Players Analysis 13.1 Mylan pharmaceuticals Inc. 13.1.1 Mylan pharmaceuticals Inc. Company Information 13.1.2 Mylan pharmaceuticals Inc. Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.1.3 Mylan pharmaceuticals Inc. Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Mylan pharmaceuticals Inc. Main Business Overview 13.1.5 Mylan pharmaceuticals Inc. Latest Developments 13.2 Baxter International Inc. 13.2.1 Baxter International Inc. Company Information 13.2.2 Baxter International Inc. Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.2.3 Baxter International Inc. Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Baxter International Inc. Main Business Overview 13.2.5 Baxter International Inc. Latest Developments 13.3 Alara Pharmaceutical Corporation 13.3.1 Alara Pharmaceutical Corporation Company Information 13.3.2 Alara Pharmaceutical Corporation Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.3.3 Alara Pharmaceutical Corporation Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Alara Pharmaceutical Corporation Main Business Overview 13.3.5 Alara Pharmaceutical Corporation Latest Developments 13.4 Abbott laboratories 13.4.1 Abbott laboratories Company Information 13.4.2 Abbott laboratories Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.4.3 Abbott laboratories Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Abbott laboratories Main Business Overview 13.4.5 Abbott laboratories Latest Developments 13.5 Bristol Myers co. 13.5.1 Bristol Myers co. Company Information 13.5.2 Bristol Myers co. Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.5.3 Bristol Myers co. Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Bristol Myers co. Main Business Overview 13.5.5 Bristol Myers co. Latest Developments 13.6 Teva parenteral medicines Inc. 13.6.1 Teva parenteral medicines Inc. Company Information 13.6.2 Teva parenteral medicines Inc. Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.6.3 Teva parenteral medicines Inc. Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Teva parenteral medicines Inc. Main Business Overview 13.6.5 Teva parenteral medicines Inc. Latest Developments 13.7 Jerome Stevens Pharmaceuticals Inc. 13.7.1 Jerome Stevens Pharmaceuticals Inc. Company Information 13.7.2 Jerome Stevens Pharmaceuticals Inc. Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.7.3 Jerome Stevens Pharmaceuticals Inc. Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Jerome Stevens Pharmaceuticals Inc. Main Business Overview 13.7.5 Jerome Stevens Pharmaceuticals Inc. Latest Developments 13.8 Merck 13.8.1 Merck Company Information 13.8.2 Merck Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.8.3 Merck Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Merck Main Business Overview 13.8.5 Merck Latest Developments 13.9 Novartis 13.9.1 Novartis Company Information 13.9.2 Novartis Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.9.3 Novartis Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Novartis Main Business Overview 13.9.5 Novartis Latest Developments 13.10 Pfizer 13.10.1 Pfizer Company Information 13.10.2 Pfizer Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.10.3 Pfizer Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 Pfizer Main Business Overview 13.10.5 Pfizer Latest Developments 13.11 Sanofi 13.11.1 Sanofi Company Information 13.11.2 Sanofi Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.11.3 Sanofi Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 Sanofi Main Business Overview 13.11.5 Sanofi Latest Developments 13.12 GalaxoSmithKline 13.12.1 GalaxoSmithKline Company Information 13.12.2 GalaxoSmithKline Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.12.3 GalaxoSmithKline Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.12.4 GalaxoSmithKline Main Business Overview 13.12.5 GalaxoSmithKline Latest Developments 13.13 Biogen Idec 13.13.1 Biogen Idec Company Information 13.13.2 Biogen Idec Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.13.3 Biogen Idec Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.13.4 Biogen Idec Main Business Overview 13.13.5 Biogen Idec Latest Developments 13.14 Bayer Healthcare Pharmaceuticals 13.14.1 Bayer Healthcare Pharmaceuticals Company Information 13.14.2 Bayer Healthcare Pharmaceuticals Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.14.3 Bayer Healthcare Pharmaceuticals Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.14.4 Bayer Healthcare Pharmaceuticals Main Business Overview 13.14.5 Bayer Healthcare Pharmaceuticals Latest Developments 13.15 Johnson & Johnson 13.15.1 Johnson & Johnson Company Information 13.15.2 Johnson & Johnson Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.15.3 Johnson & Johnson Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.15.4 Johnson & Johnson Main Business Overview 13.15.5 Johnson & Johnson Latest Developments 13.16 Tolero Pharmaceutical 13.16.1 Tolero Pharmaceutical Company Information 13.16.2 Tolero Pharmaceutical Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.16.3 Tolero Pharmaceutical Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.16.4 Tolero Pharmaceutical Main Business Overview 13.16.5 Tolero Pharmaceutical Latest Developments 14 Research Findings and Conclusion
SummaryThe global Papillary Thyroid Cancer Treatment market size is projected to grow from US$ 2690.2 million in 2022 to US$ 3780.2 million in 2029; it is expected to grow at a CAGR of 5.0% from 2023 to 2029. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Papillary Thyroid Cancer Treatment Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Papillary Thyroid Cancer Treatment by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Papillary Thyroid Cancer Treatment by Country/Region, 2018, 2022 & 2029 2.2 Papillary Thyroid Cancer Treatment Segment by Type 2.2.1 Surgery 2.2.2 Iodine Therapy 2.2.3 Thyroxin Treatment 2.2.4 Chemotherapy 2.2.5 Others 2.3 Papillary Thyroid Cancer Treatment Sales by Type 2.3.1 Global Papillary Thyroid Cancer Treatment Sales Market Share by Type (2018-2023) 2.3.2 Global Papillary Thyroid Cancer Treatment Revenue and Market Share by Type (2018-2023) 2.3.3 Global Papillary Thyroid Cancer Treatment Sale Price by Type (2018-2023) 2.4 Papillary Thyroid Cancer Treatment Segment by Application 2.4.1 Hospital Pharmacies 2.4.2 Retail Pharmacies 2.4.3 Online Pharmacies 2.5 Papillary Thyroid Cancer Treatment Sales by Application 2.5.1 Global Papillary Thyroid Cancer Treatment Sale Market Share by Application (2018-2023) 2.5.2 Global Papillary Thyroid Cancer Treatment Revenue and Market Share by Application (2018-2023) 2.5.3 Global Papillary Thyroid Cancer Treatment Sale Price by Application (2018-2023) 3 Global Papillary Thyroid Cancer Treatment by Company 3.1 Global Papillary Thyroid Cancer Treatment Breakdown Data by Company 3.1.1 Global Papillary Thyroid Cancer Treatment Annual Sales by Company (2018-2023) 3.1.2 Global Papillary Thyroid Cancer Treatment Sales Market Share by Company (2018-2023) 3.2 Global Papillary Thyroid Cancer Treatment Annual Revenue by Company (2018-2023) 3.2.1 Global Papillary Thyroid Cancer Treatment Revenue by Company (2018-2023) 3.2.2 Global Papillary Thyroid Cancer Treatment Revenue Market Share by Company (2018-2023) 3.3 Global Papillary Thyroid Cancer Treatment Sale Price by Company 3.4 Key Manufacturers Papillary Thyroid Cancer Treatment Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Papillary Thyroid Cancer Treatment Product Location Distribution 3.4.2 Players Papillary Thyroid Cancer Treatment Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Papillary Thyroid Cancer Treatment by Geographic Region 4.1 World Historic Papillary Thyroid Cancer Treatment Market Size by Geographic Region (2018-2023) 4.1.1 Global Papillary Thyroid Cancer Treatment Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Papillary Thyroid Cancer Treatment Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Papillary Thyroid Cancer Treatment Market Size by Country/Region (2018-2023) 4.2.1 Global Papillary Thyroid Cancer Treatment Annual Sales by Country/Region (2018-2023) 4.2.2 Global Papillary Thyroid Cancer Treatment Annual Revenue by Country/Region (2018-2023) 4.3 Americas Papillary Thyroid Cancer Treatment Sales Growth 4.4 APAC Papillary Thyroid Cancer Treatment Sales Growth 4.5 Europe Papillary Thyroid Cancer Treatment Sales Growth 4.6 Middle East & Africa Papillary Thyroid Cancer Treatment Sales Growth 5 Americas 5.1 Americas Papillary Thyroid Cancer Treatment Sales by Country 5.1.1 Americas Papillary Thyroid Cancer Treatment Sales by Country (2018-2023) 5.1.2 Americas Papillary Thyroid Cancer Treatment Revenue by Country (2018-2023) 5.2 Americas Papillary Thyroid Cancer Treatment Sales by Type 5.3 Americas Papillary Thyroid Cancer Treatment Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Papillary Thyroid Cancer Treatment Sales by Region 6.1.1 APAC Papillary Thyroid Cancer Treatment Sales by Region (2018-2023) 6.1.2 APAC Papillary Thyroid Cancer Treatment Revenue by Region (2018-2023) 6.2 APAC Papillary Thyroid Cancer Treatment Sales by Type 6.3 APAC Papillary Thyroid Cancer Treatment Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Papillary Thyroid Cancer Treatment by Country 7.1.1 Europe Papillary Thyroid Cancer Treatment Sales by Country (2018-2023) 7.1.2 Europe Papillary Thyroid Cancer Treatment Revenue by Country (2018-2023) 7.2 Europe Papillary Thyroid Cancer Treatment Sales by Type 7.3 Europe Papillary Thyroid Cancer Treatment Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Papillary Thyroid Cancer Treatment by Country 8.1.1 Middle East & Africa Papillary Thyroid Cancer Treatment Sales by Country (2018-2023) 8.1.2 Middle East & Africa Papillary Thyroid Cancer Treatment Revenue by Country (2018-2023) 8.2 Middle East & Africa Papillary Thyroid Cancer Treatment Sales by Type 8.3 Middle East & Africa Papillary Thyroid Cancer Treatment Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Papillary Thyroid Cancer Treatment 10.3 Manufacturing Process Analysis of Papillary Thyroid Cancer Treatment 10.4 Industry Chain Structure of Papillary Thyroid Cancer Treatment 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Papillary Thyroid Cancer Treatment Distributors 11.3 Papillary Thyroid Cancer Treatment Customer 12 World Forecast Review for Papillary Thyroid Cancer Treatment by Geographic Region 12.1 Global Papillary Thyroid Cancer Treatment Market Size Forecast by Region 12.1.1 Global Papillary Thyroid Cancer Treatment Forecast by Region (2024-2029) 12.1.2 Global Papillary Thyroid Cancer Treatment Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Papillary Thyroid Cancer Treatment Forecast by Type 12.7 Global Papillary Thyroid Cancer Treatment Forecast by Application 13 Key Players Analysis 13.1 Mylan pharmaceuticals Inc. 13.1.1 Mylan pharmaceuticals Inc. Company Information 13.1.2 Mylan pharmaceuticals Inc. Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.1.3 Mylan pharmaceuticals Inc. Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Mylan pharmaceuticals Inc. Main Business Overview 13.1.5 Mylan pharmaceuticals Inc. Latest Developments 13.2 Baxter International Inc. 13.2.1 Baxter International Inc. Company Information 13.2.2 Baxter International Inc. Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.2.3 Baxter International Inc. Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 Baxter International Inc. Main Business Overview 13.2.5 Baxter International Inc. Latest Developments 13.3 Alara Pharmaceutical Corporation 13.3.1 Alara Pharmaceutical Corporation Company Information 13.3.2 Alara Pharmaceutical Corporation Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.3.3 Alara Pharmaceutical Corporation Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 Alara Pharmaceutical Corporation Main Business Overview 13.3.5 Alara Pharmaceutical Corporation Latest Developments 13.4 Abbott laboratories 13.4.1 Abbott laboratories Company Information 13.4.2 Abbott laboratories Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.4.3 Abbott laboratories Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Abbott laboratories Main Business Overview 13.4.5 Abbott laboratories Latest Developments 13.5 Bristol Myers co. 13.5.1 Bristol Myers co. Company Information 13.5.2 Bristol Myers co. Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.5.3 Bristol Myers co. Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 Bristol Myers co. Main Business Overview 13.5.5 Bristol Myers co. Latest Developments 13.6 Teva parenteral medicines Inc. 13.6.1 Teva parenteral medicines Inc. Company Information 13.6.2 Teva parenteral medicines Inc. Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.6.3 Teva parenteral medicines Inc. Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Teva parenteral medicines Inc. Main Business Overview 13.6.5 Teva parenteral medicines Inc. Latest Developments 13.7 Jerome Stevens Pharmaceuticals Inc. 13.7.1 Jerome Stevens Pharmaceuticals Inc. Company Information 13.7.2 Jerome Stevens Pharmaceuticals Inc. Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.7.3 Jerome Stevens Pharmaceuticals Inc. Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 Jerome Stevens Pharmaceuticals Inc. Main Business Overview 13.7.5 Jerome Stevens Pharmaceuticals Inc. Latest Developments 13.8 Merck 13.8.1 Merck Company Information 13.8.2 Merck Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.8.3 Merck Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Merck Main Business Overview 13.8.5 Merck Latest Developments 13.9 Novartis 13.9.1 Novartis Company Information 13.9.2 Novartis Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.9.3 Novartis Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Novartis Main Business Overview 13.9.5 Novartis Latest Developments 13.10 Pfizer 13.10.1 Pfizer Company Information 13.10.2 Pfizer Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.10.3 Pfizer Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 Pfizer Main Business Overview 13.10.5 Pfizer Latest Developments 13.11 Sanofi 13.11.1 Sanofi Company Information 13.11.2 Sanofi Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.11.3 Sanofi Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 Sanofi Main Business Overview 13.11.5 Sanofi Latest Developments 13.12 GalaxoSmithKline 13.12.1 GalaxoSmithKline Company Information 13.12.2 GalaxoSmithKline Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.12.3 GalaxoSmithKline Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.12.4 GalaxoSmithKline Main Business Overview 13.12.5 GalaxoSmithKline Latest Developments 13.13 Biogen Idec 13.13.1 Biogen Idec Company Information 13.13.2 Biogen Idec Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.13.3 Biogen Idec Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.13.4 Biogen Idec Main Business Overview 13.13.5 Biogen Idec Latest Developments 13.14 Bayer Healthcare Pharmaceuticals 13.14.1 Bayer Healthcare Pharmaceuticals Company Information 13.14.2 Bayer Healthcare Pharmaceuticals Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.14.3 Bayer Healthcare Pharmaceuticals Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.14.4 Bayer Healthcare Pharmaceuticals Main Business Overview 13.14.5 Bayer Healthcare Pharmaceuticals Latest Developments 13.15 Johnson & Johnson 13.15.1 Johnson & Johnson Company Information 13.15.2 Johnson & Johnson Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.15.3 Johnson & Johnson Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.15.4 Johnson & Johnson Main Business Overview 13.15.5 Johnson & Johnson Latest Developments 13.16 Tolero Pharmaceutical 13.16.1 Tolero Pharmaceutical Company Information 13.16.2 Tolero Pharmaceutical Papillary Thyroid Cancer Treatment Product Portfolios and Specifications 13.16.3 Tolero Pharmaceutical Papillary Thyroid Cancer Treatment Sales, Revenue, Price and Gross Margin (2018-2023) 13.16.4 Tolero Pharmaceutical Main Business Overview 13.16.5 Tolero Pharmaceutical Latest Developments 14 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医薬)の最新刊レポート
LP Information社の医薬品・ヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD(cancer)の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |